The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab.
Rifaquat Rahman
No relevant relationships to disclose
Alhafidz Hamdan
No relevant relationships to disclose
Rebecca Zweifler
No relevant relationships to disclose
Han Jiang
No relevant relationships to disclose
Andrew David Norden
No relevant relationships to disclose
David A. Reardon
No relevant relationships to disclose
Srinivasan Mukundan
No relevant relationships to disclose
Patrick Y. Wen
No relevant relationships to disclose
Raymond Yi-kun Huang
No relevant relationships to disclose